首页 >
法规速递
-
Document: Minutes - Management Board meeting: 2 October 2025-2025/12/1
2025-12-02查看详情 > -
Document: Composition of the Emergency Task Force (ETF) for preparedness-2026/1/5
2026-01-06查看详情 > -
Document: Concept paper on the revision of the guidelines on Good Manufacturing Practice for medicinal products - Annex 15 - Qualification and validation-2026/2/9
2026-02-10查看详情 > -
General Considerations for the Use of New Approach Methodologies in Drug Development-2026/3/18
2026-03-19查看详情 > -
CVM GFI #91 (VICH GL8 (R)) Stability Testing for Medicated Premix (or Type A Medicated Article) (Revision 1)-2026/4/21
2026-04-22查看详情 > -
Document: PDCO minutes of the 21-24 April 2026 meeting-2026/6/3
2026-06-04查看详情 > -
Document: Draft reflection paper on particulars for safety signals for (traditional) herbal medicinal products-2026/7/15
2026-07-16查看详情 > -
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA(Draft)-2023/02/17
2023-02-17查看详情 > -
国家药监局关于适用《S12：基因治疗产品非临床生物分布的考虑》国际人用药品注册技术协调会 指导原则的公告（2023年第115号）-2023/9/5
2023-09-06查看详情 > -
Validation and Verification of Analytical Testing Methods Used for Tobacco Products-2025/1/6
2025-01-07查看详情 >
